Evolution of Streptococcus pneumoniae antibiotic resistance in Abidjan: Update on nasopharyngeal carriage, from 1997 to 2001;Évolution de la résistance de Streptococcus pneumoniae aux antibiotiques à Abidjan: Enquêtes de portage nasopharyngé de 1997 à 2001

Medecine et Maladies Infectieuses

Volumn 34, Issue 2, 2004, Pages 83-85

  Kacou N'douba, A ^a   Guessennd Kouadio, N ^a   Kouassi M'bengue, A ^a   Dosso, M ^a  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

Author keywords

Antibiotic resistance; Nasopharyngeal carriage; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; EVOLUTION; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NASOPHARYNX; PREVALENCE; SAMPLE; SCREENING; STREPTOCOCCUS PNEUMONIAE; COTE D'IVOIRE; DRUG EFFECT; HETEROZYGOTE; MICROBIOLOGY; PATHOGENICITY; PENICILLIN RESISTANCE; STREPTOCOCCUS INFECTION;

ANTI-INFECTIVE AGENTS; CARRIER STATE; COTE D'IVOIRE; HUMANS; NASOPHARYNX; PENICILLIN G; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0842326510     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2003.02.001     Document Type: Article

References (9)

1. Hansman D., Bullen M.M. A resistant pneumococcus. Lancet. ii:1967;264-265.
2. Benbachir M., Benredjeb S., Boye C.S., Dosso M., Belabbes H.K., et al. Two years surveillance of antibiotics resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother. 45:2001;627-629.
3. Homoe P., Prag J., Farholt S., Henrichsen J., Hornsleth A., Kilian M., et al. High rate of nasopharyngeal carriage of potential pathogens among children in Greenland: resuslts of clinical survey of middle-ear disease. Clin Infect Dis. 23:1996;1081-1090.
4. Performance standards for antimicrobial susceptibility testing: eight informational supplement. NCCLS document M 100S8. 1998;National Committee for Clinical Laboratory Standards, Villanova, Pennsylvania.
5. Joloba M.L., Bajaksouzian S., Palavecino E., Whalen C., Jacobs M.R. High prevalence of carriage of antiobiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda. Int J Antimicrob Agents. 17:(5):2001;395-400.
6. Laurens G., Murbach V., Cattier B., Chomarat M., Cottin J., Demachy M.C., et al. Observatoires régionaux du pneumocoque: surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France en 1999. BEH. 33:2001.
7. Dellamonica P., Pradier C., Leroy J., Carsenti-Etesse H., Dupont M.J., Roussel-Delcallez, et al. Épidémiologie et sensibilité aux antibiotiques des souches nasopharyngées de S. pneumoniae et de H. influenzae d'enfants fréquentant les crèches de trois départements français. Méd Mal Infect. 32:(12):2002;650- 661.
8. Trallero-Pérez E., Fernandez-Mazarrasa C., Garcia-Rey C., Bouza E., Aguilar L., Garcia-de-Lomas J., et al. Antimicrobial susceptibilities of 1,684Streptococcus pneumoniae and 2,039Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. AAC. 45:(12):2001;3334-3340.
9. L'OMS et L'Onusida saluent le consensus sur l'utilisation du cotrimoxazole dans la prévention des infections associées au VIH en Afrique. Communiqué de presse OMS/23 du 5 avril. 2000.